Ignite Creation Date:
2024-05-05 @ 11:36 AM
Last Modification Date:
2024-10-26 @ 9:10 AM
Study NCT ID:
NCT00089102
Status:
TERMINATED
Last Update Posted:
2018-07-16
First Post:
2004-08-04
Brief Title:
Gemcitabine and Irinotecan in Treating Patients With Locally Advanced Unresectable or Metastatic Kidney Cancer
Sponsor:
Medical University of South Carolina
Organization:
Medical University of South Carolina
Organization Data
Organization:
Medical University of South Carolina
Class:
OTHER
Study ID:
CDR0000378044
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Medical University of South Carolina
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None